Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: A randomized controlled clinical trial

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 1, 2014, Pages

  Schmeltz, Lowell R ^a   Blevins, Thomas C ^b   Aronoff, Stephen L ^c   Ozer, Kerem ^d   Leffert, Jonathan D ^e   Goldberg, Marc A ^f   Horowitz, Barry S ^g   Bertenshaw, Richard H ^h   Troya, Pedro ⁱ   Cohen, Amy E ^j   Lanier, Ryan K ^j   Wright IV, Curtis ^j  

^a Advanced Radiology Services PC   (United States)

^b Texas Diabetes and Endocrinology   (United States)

^c Endocrine Associates of Dallas   (United States)

^d Texas Diabetes and Endocrinology   (United States)

^e North Texas Poison Center   (United States)

^f New Jersey Physicians LLC   (United States)

^g Metabolic Research Institute Inc   (United States)

^h Diabetes and Endocrine Assocs   (United States)

ⁱ Geomatics USA LLC   (United States)

^j Rock Creek Pharmaceuticals Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; ANATABINE; LEVOTHYROXINE; PLACEBO; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROPEROXIDASE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; HASHIMOTO DISEASE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN; VOMITING;

ALKALOIDS; AUTOANTIBODIES; DOUBLE-BLIND METHOD; DOWN-REGULATION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HASHIMOTO DISEASE; HUMANS; IODIDE PEROXIDASE; MALE; PLACEBOS; PYRIDINES;

EID: 84892160995     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2951     Document Type: Article

References (19)

1. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;12:1200-1235.
2. Wiersinga WM. Smoking and thyroid. Clin Endocrinol (Oxf). 2013; 79:145-151.
3. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007;117:289-296.
4. Benowitz NL. Nicotine addiction. N Engl J Med. 2010;362:2295-2303.
5. Karaconji IB. Facts about nicotine toxicity. Arh Hig Rada Toksikol. 2005;56:363-371.
6. Schep LJ, Slaughter RJ, Beasley DM. Nicotinic plant poisoning. Clin Toxicol (Phila). 2009;47:771-781.
7. Caturegli P, De Remigis A, Ferlito M, et al. Anatabine ameliorates experimental autoimmune thyroiditis. Endocrinology. 2012;153:4580-4587.
8. Andersson C, Wennström P, Gry J. Nicotine alkaloids in solanaceous food plants. Tema Nord. 2003;531:1-37.
9. Bencherif M, Lippiello PM, Lucas R, Marrero MB. Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol Life Sci. 2011;68:931-949.
10. Hosur V, Loring RH. α4β2 nicotinic receptors partially mediate anti-inflammatory effects through Janus kinase 2-signal transducer and activator of transcription 3 but not calcium or cAMP signaling. Mol Pharmacol. 2011;79:167-174.
11. Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med. 2009;265:663-679.
12. Paris D, Beaulieu-Abdelahad D, Bachmeier C, et al. Anatabine lowers Alzheimer's Aβ production in vitro and in vivo. Eur J Pharmacol. 2011;670:384-391.
13. Paris D, Beaulieu-Abdelahad D, Mullan M, et al. Amelioration of experimental autoimmune encephalomyelitis by anatabine. PloS One. 2013;8:e55392.
14. Paris D, Beaulieu-Abdelahad D, Abdullah L, et al. Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation. Eur J Pharmacol. 2013;698:145-153.
15. Pedersen IB, Laurberg P, Knudsen N, et al. Smoking is negatively associated with the presence of thyroglobulin autoantibody and to a lesser degree with thyroid peroxidase autoantibody in serum: a population study. Eur J Endocrinol. 2008;158:367-373.
16. Männistö T, Hartikainen AL, Vääräsmäki M, et al. Smoking and early pregnancy thyroid hormone and anti-thyroid antibody levels in euthyroid mothers of the Northern Finland Birth Cohort 1986. Thyroid. 2012;22:944-950.
17. Carlé A, Laurberg P, Knudsen N, et al. Thyroid peroxidase and thyroglobulin auto-antibodies in patients with newly diagnosed overt hypothyroidism. Autoimmunity. 2006;39:497-503.
18. Chiovato L, Latrofa F, Braverman LE, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med. 2003;139:346-351.
19. Castellani ML, Shaik-Dasthagirisaheb YB, Tripodi D, et al. Interrelationship between vitamins and cytokines in immunity. J Biol Regul Homeost Agents. 2010;24:385-390.